These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 18794325)

  • 21. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report.
    Menon MM; Simha MR
    Indian J Pathol Microbiol; 2005 Apr; 48(2):161-5. PubMed ID: 16758654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple endocrine neoplasia type 2A in a kindred with C634Y mutation.
    Jackson MB; Guttenberg M; Hedrick H; Moshang T
    Pediatrics; 2005 Sep; 116(3):e468-71. PubMed ID: 16099853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of the RET proto-oncogene key exons in patients with medullary thyroid carcinoma: a comprehensive study of the Iranian population.
    Alvandi E; Akrami SM; Chiani M; Hedayati M; Nayer BN; Tehrani MR; Nakhjavani M; Pedram M
    Thyroid; 2011 Apr; 21(4):373-82. PubMed ID: 21309721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients.
    Imai T; Uchino S; Okamoto T; Suzuki S; Kosugi S; Kikumori T; Sakurai A;
    Eur J Endocrinol; 2013 May; 168(5):683-7. PubMed ID: 23416954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.
    Yip L; Cote GJ; Shapiro SE; Ayers GD; Herzog CE; Sellin RV; Sherman SI; Gagel RF; Lee JE; Evans DB
    Arch Surg; 2003 Apr; 138(4):409-16; discussion 416. PubMed ID: 12686527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship of cytomorphology of medullary thyroid carcinomas between family members with the same RET proto-oncogene mutation.
    Chang JS; Chang CF; Yang WS; Chang TC
    Acta Cytol; 2011; 55(6):556-62. PubMed ID: 22156466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RET genetic screening in patients with medullary thyroid cancer: the Moroccan experience.
    Abdelhakim A; Barlier A; Kebbou M; Benabdeljalil N; Timinouni M; Taoufiq F; Roche C; El Antri S
    J Cancer Res Ther; 2009; 5(3):198-202. PubMed ID: 19841562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the role of RET polymorphisms/haplotypes as modifier loci for MEN 2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients.
    Fernández RM; Navarro E; Antiñolo G; Ruiz-Ferrer M; Borrego S
    Int J Mol Med; 2006 Apr; 17(4):575-81. PubMed ID: 16525712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
    Moore SW; Appfelstaedt J; Zaahl MG
    J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II].
    Engelbach M; Kunt T; Kann P; Manfras B; Hankeln T; Forst T; Pfützner A; Heerdt S; Walgenbach S; Lehnert H; Beyer J
    Dtsch Med Wochenschr; 2000 Jan; 125(3):37-44. PubMed ID: 10681997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with RET D631Y mutations most commonly present with pheochromocytoma and not medullary thyroid carcinoma.
    Elston MS; Meyer-Rochow GY; Holdaway I; Conaglen JV
    Horm Metab Res; 2012 May; 44(5):339-42. PubMed ID: 22274720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family.
    Moers AM; Landsvater RM; Schaap C; Jansen-Schillhorn van Veen JM; de Valk IA; Blijham GH; Höppener JW; Vroom TM; van Amstel HK; Lips CJ
    Am J Med; 1996 Dec; 101(6):635-41. PubMed ID: 9003111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modification of multiple endocrine neoplasia 2A phenotype by cell membrane proximity of RET mutations in exon 10.
    Machens A; Hauptmann S; Dralle H
    Endocr Relat Cancer; 2009 Mar; 16(1):171-7. PubMed ID: 18936155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
    Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
    Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One hundred and seven family members with the rearranged during transfection V804M proto-oncogene mutation presenting with simultaneous medullary and papillary thyroid carcinomas, rare primary hyperparathyroidism, and no pheochromocytomas: is this a new syndrome--MEN 2C?
    Shifrin AL; Xenachis C; Fay A; Matulewicz TJ; Kuo YH; Vernick JJ
    Surgery; 2009 Dec; 146(6):998-1005. PubMed ID: 19958926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RET codon 804 mutations in multiple endocrine neoplasia 2: genotype-phenotype correlations and implications in clinical management.
    Mukherjee S; Zakalik D
    Clin Genet; 2011 Jan; 79(1):1-16. PubMed ID: 20497437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
    Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
    J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pheochromocytoma and medullary thyroid carcinoma in a pregnant multiple endocrine neoplasia-2A patient.
    Sarathi V; Bandgar TR; Menon PS; Shah NS
    Gynecol Endocrinol; 2011 Aug; 27(8):533-5. PubMed ID: 20672905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study.
    Mathiesen JS; Habra MA; Bassett JHD; Choudhury SM; Balasubramanian SP; Howlett TA; Robinson BG; Gimenez-Roqueplo AP; Castinetti F; Vestergaard P; Frank-Raue K
    J Clin Endocrinol Metab; 2017 Jun; 102(6):2069-2074. PubMed ID: 28323957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. M918V RET mutation causes familial medullary thyroid carcinoma: study of 8 affected kindreds.
    Martins-Costa MC; Cunha LL; Lindsey SC; Camacho CP; Dotto RP; Furuzawa GK; Sousa MS; Kasamatsu TS; Kunii IS; Martins MM; Machado AL; Martins JR; Dias-da-Silva MR; Maciel RM
    Endocr Relat Cancer; 2016 Dec; 23(12):909-920. PubMed ID: 27807060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.